Gemphire Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 15, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Founding Year
- 2015
- Traction
- The company has successfully completed Phase 2 clinical trials for its lead product candidate and is currently preparing for Phase 3 trials.
- Founders
- Dr. Steven A. Nissen, Dr. John D. McKinley
- Company Description
- Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular and metabolic diseases. The company is leveraging its proprietary technology platform to create innovative treatments that address significant unmet medical needs.
- Market
- Pharmaceuticals
- Location
- San Diego, California, USA